MetaADEDB 2.0 @ LMMD
miglitol
(IBAQFPQHRJAVAV-ULAWRXDQSA-N)
Structure
SMILES
OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
Type(s)
Approved
ATC code(s)
A10BF02
Molecular Formula:
C8H17NO5
Molecular Weight:
207.224
Log P:
-3.3242
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
5
TPSA:
104.39
CAS Number(s):
72432-03-2
Synonym(s)
1.
miglitol
2.
BAY m 1099
3.
BAY-m 1099
4.
BAY-m-1099
5.
Diastabol
6.
Glyset
7.
N-hydroxyethyl-1-desoxy-nojirimycin
8.
N-hydroxyethyl-1-desoxynojirimycin
9.
Plumarol
10.
miglitol, 4-methylbenzenesulfonate salt, ((D)-isomer)
External Link(s)
MeSHC045621
PubChem Compound441314
BindingDB50242271
ChEBI6935
CHEMBLCHEMBL1561
DrugBankDB00491
DrugCentral1806
IUPHAR/BPS Guide to PHARMACOLOGY4842
KEGGcpd:C07708
dr:D00625
Therapeutic Target DatabaseD0D0ZD
ZINC4097426
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedFAERS: 25OFFSIDES
US FAERS
2Aspartate Aminotransferase IncreasedFAERS: 19US FAERS
3Gamma-Glutamyltransferase IncreasedFAERS: 14OFFSIDES
US FAERS
4Pneumatosis intestinalisFAERS: 9SIDER
US FAERS
5Blood alkaline phosphatase increasedFAERS: 7OFFSIDES
US FAERS
6Intestinal ObstructionFAERS: 7OFFSIDES
SIDER
US FAERS
7IleusFAERS: 5SIDER
US FAERS
8Blood potassium increasedFAERS: 3US FAERS
9DysarthriaFAERS: 3US FAERS
10InfluenzaFAERS: 3US FAERS
11KetosisFAERS: 3US FAERS
12NauseaFAERS: 3SIDER
US FAERS
13Portal venous gasFAERS: 3US FAERS
14RhabdomyolysisFAERS: 3US FAERS
15Blood creatinine increasedFAERS: 2US FAERS
16Blood glucose increasedFAERS: 2US FAERS
17Chest discomfortFAERS: 2US FAERS
18ConstipationFAERS: 2SIDER
US FAERS
19DizzinessFAERS: 2US FAERS
20Drug ineffectiveFAERS: 2US FAERS
21DysuriaFAERS: 2US FAERS
22No adverse eventFAERS: 2US FAERS
23TremorFAERS: 2US FAERS
24Urinary RetentionFAERS: 2US FAERS
25Abdominal symptomFAERS: 1US FAERS
26AgnosiaFAERS: 1US FAERS
27AngioedemaFAERS: 1US FAERS
28AnorexiaFAERS: 1US FAERS
29Blood creatine phosphokinase increasedFAERS: 1US FAERS
30Blood glucose abnormalFAERS: 1OFFSIDES
US FAERS
31Blood lactate dehydrogenase increasedFAERS: 1US FAERS
32Blood potassium decreasedFAERS: 1US FAERS
33Cerebral InfarctionFAERS: 1US FAERS
34ChromaturiaFAERS: 1US FAERS
35Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
36Extra dose administeredFAERS: 1US FAERS
37FatigueFAERS: 1US FAERS
38FlatulenceFAERS: 1SIDER
US FAERS
39HeadacheFAERS: 1US FAERS
40HepatitisFAERS: 1US FAERS
41HypersensitivityFAERS: 1US FAERS
42Immune thrombocytopenic purpuraFAERS: 1US FAERS
43KetoacidosisFAERS: 1US FAERS
44Large intestine perforationFAERS: 1US FAERS
45LymphomaFAERS: 1OFFSIDES
US FAERS
46MalaiseFAERS: 1US FAERS
47Nephrotic SyndromeFAERS: 1US FAERS
48NeutropeniaFAERS: 1US FAERS
49Occult blood positiveFAERS: 1US FAERS
50Ocular HypertensionFAERS: 1US FAERS
51PainFAERS: 1US FAERS
52PalpitationsFAERS: 1US FAERS
53Product dispensing errorFAERS: 1US FAERS
54SinusitisFAERS: 1US FAERS
55ThirstFAERS: 1US FAERS
56ThrombocytopeniaFAERS: 1US FAERS
57TinnitusFAERS: 1US FAERS
58Transaminases increasedFAERS: 1OFFSIDES
US FAERS
59Vascular purpuraFAERS: 1US FAERS
60VomitingFAERS: 1US FAERS
61Abdominal PainOFFSIDES
SIDER
62Acid refluxOFFSIDES
63Acute Coronary SyndromeOFFSIDES
64Acute bronchitisOFFSIDES
65Acute sinusitisOFFSIDES
66Adams-Stokes SyndromeOFFSIDES
67Anal FissureOFFSIDES
68Anal FistulaOFFSIDES
69Anti-insulin antibody positiveOFFSIDES
70Anticonvulsant drug level decreasedOFFSIDES
71AtherosclerosisOFFSIDES
72Benign Prostatic HyperplasiaOFFSIDES
73Bilirubin conjugated increasedOFFSIDES
74Blood GlucoseOFFSIDES
75Blood chloride decreasedOFFSIDES
76Blood creatine phosphokinase MB increasedOFFSIDES
77Blood creatine phosphokinase abnormalOFFSIDES
78Blood glucose decreasedOFFSIDES
79Blood urine presentOFFSIDES
80Brain ContusionOFFSIDES
81Brain natriuretic peptide increasedOFFSIDES
82Bronchial irritationOFFSIDES
83BronchitisOFFSIDES
84DehydrationOFFSIDES
85DermatitisSIDER
86Diabetic RetinopathyOFFSIDES
87DiarrheaOFFSIDES
88Disseminated Intravascular CoagulationOFFSIDES
89Drug exposure during pregnancyOFFSIDES
90DysgeusiaOFFSIDES
91Emotional distressOFFSIDES
92Erosive gastritisOFFSIDES
93Essential TremorOFFSIDES
94Failure to ThriveOFFSIDES
95Gastrointestinal PainSIDER
96Heat ExhaustionOFFSIDES
97Heat illnessOFFSIDES
98Hyperglycemia20667563CTD
99Injection site cellulitisOFFSIDES
100Intestinal PerforationSIDER
101IntussusceptionSIDER
102Lymphangiosis carcinomatosaOFFSIDES
103Lymphocyte count decreasedOFFSIDES
104Lymphocyte stimulation test positiveOFFSIDES
105Metastatic Renal Cell CarcinomaOFFSIDES
106MicrocytosisOFFSIDES
107Monocyte percentage increasedOFFSIDES
108Myoglobin blood increasedOFFSIDES
109NasopharyngitisOFFSIDES
110OliguriaOFFSIDES
111OsteomyelitisOFFSIDES
112OsteoporosisOFFSIDES
113PhotodermatosisOFFSIDES
114Pneumatosis Cystoides IntestinalisSIDER
115PneumoperitoneumSIDER
116PolyuriaOFFSIDES
117Product quality issueOFFSIDES
118Renal graft lossOFFSIDES
119Renal tubular acidosisOFFSIDES
120Spinal column stenosisOFFSIDES
121SubileusOFFSIDES
SIDER
122Systolic hypertensionOFFSIDES
123Urethral dischargeOFFSIDES
124fibromaOFFSIDES
125prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.